Each tablet contains:
Active ingredient:
| Chymotrypsin | 4200 USP units |
Excipients: Maltodextrin, aspartame, compri M3 fine, menthol powder, magnesium stearate.
_Bostryspin_900x900.png)
BOSTRYPSIN
202207-0259 • 2439 Views • Box of 10 blisters × 10 tablets
COMPOSITION
BOSTRYPSIN is used for treatment of post - traumatic or postoperation oedema (i.e., soft tissue injuries, acute traumatic injuries, sprains, contusions, hematomas, ecchymoses, infections, edema of the eyelids , muscle cramps, and sports injuries).
ADMINISTRATION AND DOSAGE
Administration
Tablets should also be taken with at least 8 oz (ounce) equivalent to 240 ml of water to help activate the enzyme.
Dosage
2 tablets, 3 to 4 times/day.
CONTRAINDICATIONS
Hypersensitivity to chymotrypsin or any of the other components of the product.
Chymotrypsin is contraindicated in patients with decreased alpha 1 antitrypsine. Generally, patients with COPD, especially emphysema and patients presenting with nephrotic syndrome are also likely candidates for decreased alpha 1 antitrypsine.
WARNINGS AND PRECAUTIONS
Chymotrypsin is generally well tolerated and not
associated with any significant side effects.
People who should not use enzyme therapy include those
with hereditary clotting disorders such as hemophilia,
those suffering from coagulation disturbances, those who
are just about to or have undergone surgery, those on
anticoagulant therapy, anyone suffering from protein
allergies, and pregnant women or those breast-feeding,
patient has stomach ulcers.
Important information about excipients
BOSTRYPSIN contains 6 mg aspartame in each tablet. Neither non-clinical nor clinical data are available to assess aspartame use in infants below 12 weeks of age.
PREGNANCY AND LACTATION
Chymotrypsin should not be used in pregnant and breast-feeding women.
SHELF-LIFE
24 months from the manufacturing date. Do not use after the expiry date.
Alu/Alu blister. Box of 10 blisters × 10 tablets
Your comment
Similar products
Recently Viewed Products
Hotline: 19001910
Cooperate with us
Career opportunities
Sign up for more information
BOSTON VIETNAM PHARMACEUTICAL JOINT STOCK COMPANY
Factory: No. 43, 8th Street, Vietnam - Singapore Industrial Park, Binh Hoa Ward, Ho Chi Minh City, Vietnam. Phone: (0274) 3769 606
Office:
- At Lisbon Capital (Portugal): Campo Grande nº 28, 3.º C, - lisbon, district of Lisbon, municipality of Lisbon, parish of Alvalade.
Phone: 1900 1910
- At Ha Noi City: No.38 Duc Giang Street, Viet Hung Ward, Ha Noi City, Vietnam.
Phone: (024) 7305 0606
- At Da Nang City: No.01, Ham Trung 4 Street, Hai Van Ward, Da Nang City, Vietnam.
Phone: (023) 6730 3737
- At Nha Trang City: No.29, Thai Thong Street, Nam Nha Trang Ward, Khanh Hoa Province, Vietnam.
Phone: (025) 8730 3969
- At Ho Chi Minh City: 4th Floor, Flemington Tower, 182 Le Dai Hanh, Phu Tho Ward, Ho Chi Minh City, Vietnam.
Phone: (028) 3838 0606
- At Can Tho City: No.S2-3-4-5, 10th Street, Lot 11C RIVERINE Cantho City, Hung Phu Ward, Can Tho City, Vietnam.
Phone: (029) 2730 5959
Business Registration Certificate: No. 3700843113 issued by Binh Duong Province Department of Planning and Investment on January 11, 2007
Representative: Mr. Luong Dang Khoa.
Connect with Boston Pharma
Copyright © 2019 BOSTON VIET NAM
